Related Experiment Video
Updated: Oct 9, 2025

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
[Extracellular vesicles and cardiovascular diseases]
Pierre-Michael Coly1, Xavier Loyer1
1Université de Paris, Inserm UMR 970, Paris-Centre de recherche cardiovasculaire (Paris-Cardiovascular Research Center), 56 rue Leblanc, F-75015 Paris, France.
Insights
Extracellular vesicles (EVs) are key to intercellular communication in cardiovascular diseases. This review explores their dual role in disease and potential as diagnostic and therapeutic tools.
Area of Science:
- Cardiovascular Medicine
- Cell Biology
- Biotechnology
Background:
- Cardiovascular diseases (CVDs) are a leading global cause of mortality, necessitating novel therapeutic and diagnostic strategies.
- Extracellular vesicles (EVs) mediate intercellular communication and are implicated in cardiovascular pathophysiology.
- The role of EVs in CVDs is complex, varying with their origin and cargo, presenting both challenges and opportunities.
Purpose of the Study:
- To review recent advancements in understanding the role of extracellular vesicles (EVs) in cardiovascular pathologies.
- To highlight the potential of EVs as diagnostic biomarkers and therapeutic agents for cardiovascular diseases.
Main Methods:
- Literature review of recent research on extracellular vesicles and cardiovascular diseases.
- Analysis of studies investigating EV function in inflammation, angiogenesis, and other CVD-related pathways.
- Synthesis of findings on the dual role of EVs (deleterious vs. therapeutic) in cardiovascular contexts.
Main Results:
- Extracellular vesicles (EVs) actively regulate key cardiovascular pathways, including inflammation and angiogenesis.
- EVs exhibit a context-dependent role in cardiovascular diseases, influenced by their source and molecular contents.
- Emerging evidence supports the use of EVs as promising diagnostic biomarkers and therapeutic agents for CVDs.
Conclusions:
- Extracellular vesicles (EVs) are pivotal in cardiovascular disease development and progression.
- Targeting or utilizing EVs offers innovative avenues for cardiovascular disease diagnosis and treatment.
- Further research into EV biology is crucial for unlocking their full clinical potential in cardiology.
Abstract:
Cardiovascular diseases remain the leading cause of death globally. There is therefore a need to develop new approaches for the treatment and early detection of these ailments. In the past decades, extracellular vesicles (EVs) have attracted significant attention as their role in intercellular communication has been brought to light. They have been shown to regulate pathways such as cellular inflammation or angiogenesis, and are therefore involved in key aspects of cardiovascular pathophysiology. Interestingly, EVs appear to have a multifaceted role which depends on their origin and cargo. Though at times deleterious, they have also been proposed as promising diagnostic tools and potential therapeutics. This review highlights recent advances in the role of extracellular vesicles in cardiovascular pathologies.
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Intralumenal Vesicles and Multivesicular Bodies
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Overview of the Vascular System
Coronary Artery Disease II: Pathophysiology

